Ringgit books gains after four days of losses


KUALA LUMPUR: The ringgit ended on a firmer footing Friday as investors cheered good news on the opening of the US economy and encouraging developments in Gilead Sciences’ Covid-19 treatment drug trial.

At 6 pm, the ringgit improved to 4.3650/3750 against the US dollar from 4.3700/3780 at the close on Thursday.

Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

ringgit , US dollar , Covid-19 , China , Gilead Sciences

   

Next In Business News

Industrial projects look increasingly attractive
Protecting trade is protecting yourself
Dutch Lady’s balancing act amid escalating costs
Fed dampens hopes for rate cut
F&N to use cost management measures
Yew Lee expects to return to profitability on wider customer base
Naza makes entry into green economy
CapBay aims to provide financing to more SMEs
Changing office space requirements
New initiative for infrastructure needs in Perak

Others Also Read